EN | UA
EN | UA

Help Support

Back

A recap of the 2023 International Guideline for PCOS assessment and care

PCOS PCOS
PCOS PCOS

Globally, an estimated 1.55 million females of reproductive age are affected by Polycystic Ovary Syndrome (PCOS), contributing to approximately 0.43 million disability-adjusted life years.

See All

Key take away

Emphasizing patient education, shared decision-making, and minimizing weight bias, the Revised 2023 Guidelines for PCOS recommend combined oral contraceptives for menstrual irregularity and hyperandrogenism, Letrozole for infertility, and IVF with single embryo transfer as third-line therapy.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: